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Sleep and Sleep 
Disorders in Later Life
by Robert D. Vorona, MD
Educational Objectives
1. Describe basic changes in sleep
that occur as we age.
2. Review several important sleep
disorders common in later life 
3. Discuss treatment modalities for
these sleep disorders and potential
benefits of therapy.
Background
Many of us may have little under-
standing of sleep and the changes
that occur as we age. Sleep is not a
unitary process but rather subdi-
vides into non-REM (rapid eye
movement) sleep and REM or
dreaming sleep. Non-REM sleep is
then broken up into Stage 1, Stage
2, and Stage 3 sleep.   One enters
sleep through the portal of light
Stage 1 sleep, which normally takes
up only about 5% of the night.  The
next stage of light sleep is Stage 2
sleep, which generally encompasses
roughly 50% of the night. Sleep
spindles and K complexes on the
electroencephalogram (EEG) mark
Stage 2 sleep.  Particularly when
young, we tend to have about 20-
25% of the night comprised of
Stage 3 or deep sleep. Stage 3
sleep, the final portion of non-REM
sleep, is defined by the presence of
low frequency and high voltage
EEG waves called delta or slow
waves.   As we grow old, we tend to
lose this deep sleep and this attenu-
ation in deep sleep is often more
marked in males than females. We
tend to be least easily awakened
from Stage 3 sleep. 
REM sleep differs greatly from
non-REM sleep and is defined by
rapid eye movements, loss of chin
muscle tone, and a low voltage and
mixed frequency EEG. Unlike deep
sleep, the percentage of REM sleep
does not change much over time
and generally involves 20-25% of
the night. Interestingly, with the
exception of our eye muscles and
our diaphragm (the principal mus-
cle of respiration), we are paralyzed
during REM sleep. 
In general, it takes about 15 min-
utes to enter Stage 2 sleep. This
period from wakefulness to Stage 2
sleep is called the sleep latency to
Stage 2. It then takes about 90-110
minutes from the onset of sleep
until we enter our first period of
REM sleep. Thereafter, we cycle
through non-REM and REM sleep
through the night, generally about
three to five REM periods a night
for adults. Most of our deep sleep is
localized to the first half of the
night and most of our REM sleep
occurs during the second half of the
night. REM periods generally
become longer during the night. A
long first REM period can clue a
sleep specialist to the possibility of
a depression.
How long should we sleep? This
question elicits some controversy
and depends greatly on one’s age.
For example, high school students
seem to require 9.25 hours of sleep
a night. Adults (including the aged)
tend to require less sleep than teens,
with many specialists recommend-
ing about seven to eight hours of
sleep a night. Studies suggest that
the lowest mortality in adults is
associated with approximately
seven hours of sleep a night. Both
significantly less sleep and greater
sleep amounts are associated with
reports of greater mortality, for rea-
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2restricted sleep has been associated
with such important sleep disorders
as hypertension, diabetes mellitus,
and obesity (e.g., Vorona et al.
2005). Whether prolonging sleep
duration will lower blood pressure,
lower blood sugar, or help reduce
weight remains to be established.  
Older Adults
One consequence of aging is a
reduction in deep or slow wave
sleep. However, a number of other
changes in sleep occur with aging.
We tend to spend more time in bed
awake. Sleep efficiency is defined
as the proportion of time one is
asleep while in the bed. In healthy
sleepers, sleep efficiency is approx-
imately 90%. However, in the
elderly sleep efficiency might drop
to as low as 70%.  Older adults tend
to “phase advance” with their inter-
nal clocks encouraging an earlier
bed time and earlier wake time.
Such a phase advance should not be
problematic unless extreme, impair-
ing one’s ability to live an active
social life. Further, older adults tend
to spend more time in lighter stages
of sleep, have more arousals during
sleep (mini-awakenings), and to
nap more during the day than
younger adults. 
Several important sleep disorders
afflict older adults. We will high-
light obstructive sleep apnea syn-
drome (OSAS), Restless Legs Syn-
drome/Periodic limb movements of
sleep (RLS/PLMS), REM sleep
behavior disorder (RBD), and
chronic insomnia.  
OSAS is the repetitive complete or
near complete occlusion of the
upper airway during sleep.  This
syndrome is common and becomes
increasingly so, probably plateau-
ing in prevalence after age 65
(Mehra et al, 2007). Symptoms of
OSAS include snoring, nocturnal
choking, gasping and pauses, as
well as non-restorative sleep and
daytime sleepiness. Patients might
also note morning headaches, noc-
turia, mood disturbances, and
enuresis (wetting the bed). 
OSAS looks to be a common sec-
ondary cause of hypertension and
has been associated with an
increased risk of congestive heart
failure, irregular heart rhythms, and
stroke (Bradley & Floras, 2009).
Moderate to severe and severe
OSAS have also been linked to
increases in “all-cause mortality”
(Marshall et al., 2008). For two
decades data have demonstrated
that patients with OSAS are signifi-
cantly more likely to have car
crashes (Findley et al., 1988). 
The diagnosis of OSAS is optimally
established at an American Acade-
my of Sleep Medicine accredited
sleep disorders center or accredited
sleep disordered breathing laborato-
ry. After a history and physical
examination, the patient undergoes
a polysomnogram (sleep study) at
the sleep center, during which the
patient typically spends a full eight
hours in a special bedroom. Such
sleep studies measure a number of
physiologic signals that include
brain waves, eye movements, nasal
and oral air flow, electrocardio-
gram, chest and abdominal wall
movements, oxygen level, and leg
movements. While the patient
sleeps, sleep technologists or tech-
nicians monitor the signals, trouble
shoot, and care for the patient’s
needs. Technicians subsequently
score the raw data; a sleep special-
ist then reviews their scoring and
raw data, generates a report, and
establishes a diagnosis.  OSAS is
defined by the presence of at least
five partial (hypopneas) or com-
plete pauses (apneas) in breathing
per hour of sleep, described as the
AHI or apnea-hypopnea index.
Although far from a perfect metric,
sleep specialists assume that greater
number of apneas or hypopneas
demonstrate more severe sleep
apnea.
A number of treatment options are
available for OSAS subjects.
Generic treatments can include
weight loss and reduction or avoid-
ance of alcohol. One study suggests
that a 10% decline in BMI leads to
a 26% reduction in AHI. Patients
should be instructed not to drive if
sleepy and to adopt countermea-
sures to sleepy driving that include
caffeine and napping. 
Beyond these general recommenda-
tions, positive airway pressure
(PAP), dental appliances, and
surgery offer effective OSAS treat-
ments. PAP applies a positive pres-
sure to the OSAS patient’s upper
airway, thus splinting open the air-
way and preventing the recurrent
partial or complete upper airway
occlusions of OSAS. PAP has been
demonstrated to improve quality of
life, lessen daytime sleepiness,
reduce car crash rate to baseline
rates, and improve mood (George,
2001; Kawahara et al., 2005). PAP
may also lower blood pressure,
reduce blood sugar in diabetes mel-
litus, improve insulin resistance,
and improve ventricular dysfunc-
tion in congestive heart failure
(Dorkova et al., 2008; Mansfield et
al., 2004).  Some early data even
suggest that over the long term PAP
3may reduce cardiovascular mortali-
ty. Thus, it is gratifying that an
increasing database demonstrates
the utility of treating OSAS.
Dental appliances for OSAS are
worn over the teeth during sleep
(almost akin to a football player’s
mouthguard) and can be effective in
mild to moderate sleep apnea. Most
believe that patients must have
eight to10 teeth both above and
below to anchor such devices. Den-
tal specialists should fashion these
devices.  A number of surgical pro-
cedures, usually performed by Ear
Nose and Throat surgeons and/or
Oral Maxillofacial surgeons, can
treat OSAS. With older adults who
may have co-morbidities, surgery
should be reserved for significant
OSAS that has not responded to the
application of less invasive maneu-
vers. 
Restless legs syndrome (RLS)
afflicts roughly 10% of the popula-
tion in the United States. As defined
by the International Restless Legs
Syndrome Study Group (IRLSSG),
four basic criteria must be satisfied
to diagnose RLS: 1) The patient
describes an urge to move and
almost always with accompanying
paresthesias (an antsy or creepy-
crawly sensation); 2) The urge to
move occurs at rest; 3) A clear cir-
cadian rhythm exists with symp-
toms being most problematic in the
evening/night; and 4) Movement
rapidly alleviates symptoms,
although symptoms can occur with
resumption of rest. 
Approximately 60% of those with
RLS are females and most are ages
50 or older. Patients with RLS often
complain about an inability to initi-
ate or maintain sleep and not infre-
quently manifest mood disorders.
The clinician evaluating RLS must
remember that, although many
cases of RLS are idiopathic, a num-
ber of secondary causes can under-
pin RLS. For example, iron defi-
ciency, end stage renal disease, and
multiple sclerosis have all been
associated with RLS (e,g., Hening
et al., 2007). 
Physicians and ancillary clinicians
can diagnose RLS through history
and physical examination. A
polysomnogram is superfluous if
the clinician does not suspect
another sleep disorder. Some 80%
of RLS patients demonstrate peri-
odic limb movements of sleep
(PLMS) on sleep studies. PLMS are
repetitive and stereotypic leg jerks.
RLS treatment should ensue if
symptoms are frequent enough and
onerous enough to prevent adequate
sleep. Patients should be urged to
minimize caffeine and alcohol and
to avoid anti-histamines. Some will
gain relief through warm baths,
massage or exercise. Medications to
include dopamine agonists (e.g.,
ropinirole and pramipexole),
gabapentin, and opiates all can be
effective. A recent study also sug-
gests that intermittent pneumatic
compression devices can offer relief
to RLS sufferers. 
REM sleep disorder. As noted
above, normal REM sleep leaves
the sleeper paralyzed with the
exception of diaphragm and oculo-
motor function. REM sleep behav-
ior disorder (RBD) is a fascinating
disorder in which patients act out
dreams that often are comprised of
violent content.  Patients can be
noted by their bed partner to holler
and/or punch or kick in their sleep.
Patients with RBD may abruptly
leave the bed, and are apt to injure
themselves and more likely to
injure their bed partner. RBD most
commonly afflicts older men. Eval-
uation should be performed by a
sleep specialist who may order spe-
cialized polysomnography to
include video, extra limb elec-
tromyographic leads, and more
involved electroencephalo-graphic
leads (to interrogate for seizures). A
paradoxical loss of REM atonia in
the chin, arm and/or leg EMG leads
strongly supports RBD.
Treatment of RBD should first
involve making the bed area safe
for both patient and the bed partner.
Clonazepam effectively attenuates
RBD symptoms in roughly 90% of
patients (Olsen et al., 2000). Case
reports suggest that caffeine can
exacerbate RBD, so a reduction of
intake could be worthwhile. Clini-
cians should be alert to the use of
selective serotonin reuptake
inhibitors (certain antidepressants)
in patients who present with RBD.
Finally, RBD not infrequently pre-
sents with or presages degenerative
neurological diseases such as
Parkinson’s disease and Lewy Body
dementia (Olsen et al., 2000). A full
neurological evaluation in patients
with RBD is worthwhile.   
Chronic insomnia. One can define
insomnia as the inability to initiate
sleep or maintain sleep, the pres-
ence of early morning awakenings
or the belief that sleep quality is
poor. These complaints should
occur in the presence of an ade-
quate opportunity to sleep and with
daytime impairment. Insomnia
more commonly troubles women
than men and occurs more often
with increasing age. Clinicians can
most effectively address insomnia
by remembering to take an orga-
nized approach that evaluates and
treats the following possible
cause(s): 1) Environmental issues
like a noisy or hot bedroom; 2)
Mood disorders, as there likely is a
bidirectional relationship between
depression and insomnia; 3) Med-
ical disorders such as asth-
ma/COPD, arthritis, reflux or pro-
statism; 4) Intrinsic sleep disorders
such as OSAS (50% of OSAS sub-
jects have insomnia complaints) or
RLS; 5) Sleep hygiene abnormali-
ties, e.g., chaotic bed and wake
times, excessive alcohol and caf-
feine or using the bed to watch TV
or work; 6) Circadian rhythm disor-
ders such as Advanced Sleep Phase
syndrome; and 7) Psychophysiolog-
ic insomnia with hyperarousal in
the bedroom and learned maladap-
tive behaviors  
Perhaps the most contentious issue
in the treatment of chronic insom-
nia involves the use of behavioral
interventions versus sleeping pills.
Most sleep specialists recommend
the use of behavioral interventions
such as stimulus control, sleep
restriction or cognitive behavioral
interventions as opposed to long
term sleeping pill use. However, a
small but burgeoning literature sup-
ports the long term use of sleeping
pills for insomnia.  
Case Study #1
Mr. S. arrived at the physician’s
office aghast that he struck his wife
last night during his sleep. This 65
year old patient relates that his
aggrieved wife awakened him
immediately and that he remem-
bered punching at an attacker in his
dream. A phone call to his wife
alerts the physician to the fact that
Mr. S. has a long history of modest
snoring but no history of nocturnal
gasping or pauses in respiration. He
has been yelling and moving in his
sleep for some time.  He admits to
no history of depression and takes
only a diuretic for his hypertension.
No family history of sleep disorders
exists and his review of systems
reveals only the recent increase in
drooling. 
On physical exam the physician
noted a subtle shuffling of gait, as
well as a resting tremor and some
cogwheel rigidity. The physician,
suspecting RBD, scheduled Mr. S.
for a sleep evaluation and probable
expanded polysomnogram. The
subsequent sleep study revealed no
sleep apnea (thus no pseudo-RBD)
but demonstrated a marked increase
in muscle tone in REM sleep. The
physician instituted clonazepam
with resolution of RBD symptoms,
and in follow-up a neurological
consultant confirmed the diagnosis
of Parkinson’s disease.  
Case Study #2
Ms. R. reported a long history of
both problems falling asleep and
staying asleep. She believes that
she obtains but six hours of sleep a
night and finds herself increasingly
irritable and unable to concentrate.
She admits to a long history of
depression that has been well con-
trolled through the use of bupropi-
on. She notes that two previous
physicians have treated her insom-
nia with zolpidem and more recent-
ly temazepam with but modest suc-
cess. She fervently denies snoring
or witnessed pauses in respiration.
When asked to explain specifically
why she cannot sleep, she admits to
an urge at rest (and at night) to
move her legs associated with a
feeling that she simply cannot
describe. The physician then elicits
that walking quickly reduces her
symptoms but only transiently. Ms.
R. notes that she drinks seven to
eight glasses of sweet tea daily and
that her late mother had the “fid-
gets”. The physician recommends
marked reduction of caffeine and
checks a serum ferritin level, which
returns normal. Initiation of a
dopamine agonist relieves her RLS
and her insomnia.  
Conclusion
Clinicians, older adults, and others
should be alert to the possibility of
sleep disorders in later life.  Sleep
disorders in older adults are com-
mon, may have substantive conse-
quences, and often can be treated
effectively.  
Study Questions 
1. What changes occur in sleep
architecture as we age? 
2. What are some of the major con-
sequences of untreated obstructive
sleep apnea syndrome? 
3. Do most sleep specialists prefer
the use of behavioral interventions
or long term sleeping pills to treat
chronic insomnia?
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General Recommended Reading or
Sources:
A good source for the public:
www.sleepfoundation.org
Information about specific sleep prob-
lems: www.sleepeducation.com
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